Clinical Trial to Evaluate the Efficacy and Safety of YHP1701
Clinical Trial to Evaluate the Efficacy and Safety of YHP1701
The purpose of this study is to determine superiority of YHP1701 comparing to each
 monotherapy in patient with hypertension and primary hypercholesterolemia.
Inclusion Criteria:

 -  Both man and woman who is over 19 years old

 -  Patient with dyslipidemia and hypertension

 Exclusion Criteria:

 -  sSBP difference is ≥20 mmHg or sDBP difference is ≥10 mmHg

 -  A history of cardiovascular disease

 -  Rhabdomyolysis, myopathy

 -  Hypertension or hypercholesterolemia due to secondary causes

 -  Uncontrolled diabetes

 -  Evidence of hepatic or renal disease